Over 10,000 customers have rated this store since 1999
IN STOCK - YES
Chitosan HD
What Is Chitosan HD?
Chitosan HD™ / LipoSan Ultra™ is an ultra-dense form of Chitosan; the "HD" meaning "high density". According to research provided by the manufacturer, Chitosan HD™ has the ability to absorb 3 to 5 times the lipids of regular Chitosan. And, it is soluble in 3 to 5 minutes.
Who Should Consider Chitosan HD?
Are you trying to lose weight?
Are you looking for help in lowering your cholesterol?
Do you need help trying to reduce body fat?
Significant attention has been given to the role of Chitosan as a cholesterol and lipid binding agent. Chitosan is produced by the hydrolysis of chitin, a naturally occurring polysaccharide that is a major component of shellfish shell. This fat binding, lipotropic, effect may be partially explained by both the positively charged sites along its polymeric structure and its flocculation and gelation properties in the gastrointestinal tract. Once gelled, Chitosan can encapsulate over four times its own weight of negatively charged lipids.
Chitosan HD™ / LipoSan Ultra™ is an ultra-dense form of Chitosan; the "HD" meaning "high density". According to research provided by the manufacturer, Chitosan HD™ has the ability to absorb 3 to 5 times the lipids of regular Chitosan. And, it is soluble in 3 to 5 minutes.
Chitosan HD™ is soluble in stomach acid and its amino groups become positively charged via proteination by the acid. In the presence of dietary fatty acids, which carry negative charges, ionic bonds form that bind the fatty acids to the Chitosan's amino groups.
As the soluble Chitosan/fatty acid complex moves into the small intestine, it also binds with bile acids and cholesterol that are present. The complex absorbs up to 400 times its weight in water and begins to floc due to the higher, less acidic pH in the small intestine. This flocculation further aids the binding process by trapping or encapsulating all of the bound lipids, including cholesterol.
As the pH continues to increase, Chitosan HD™ floc forms an insoluble gel consisting of Chitosan, bile acids, bound lipids and cholesterol--none of which enter the blood stream. Not only is cholesterol uptake decreased, but it is believed that the continuous partial removal of bile acids from circulation by Chitosan HD™ triggers the body to produce replacement bile acid via the oxidation of already absorbed cholesterol. This produces an additional reduction in low density lipoprotein (LDL) levels.
For these reasons, Chitosan has earned the reputation as the premier lipid binder. Now Vanson researchers have been able to manufacturer Chitosan HD™ which has the ability to bind with almost three times as much lipid volume as compared to its predecessor. This new product is called Chitosan HD™ / LipoSan Ultra™.
How Can I Distinguish between High Density Chitosan and older Chitosan?
High Density Chitosan is more expensive. If a company is using it, they will brag about it. If they just say "Chitosan," it's not high density Chitosan HD™.
Important nutritional note for dieters
People need some fat in their diets, as we all need to ingest essential fatty acids, and the fat-soluble vitamins A, D, E and K. For these reasons, we recommend against using these products before every meal, every day. Regular use of any product on this page should ideally be combined with a high-quality fatty acid product, and a multivitamin containing adequate amounts of fat soluble vitamins. Take these supplements at a different time from when you take Fat Absorber or Chitosan HD™.
Side Effects
Anyone allergic to shellfish may be allergic to Chitosan HD™, as it is derived from shellfish. Remember that Vitamins A, D, E, and K are fat-soluble vitamins. So, you need some fat in order to get these vitamins. With this in mind, we recommend that you do not use Chitosan HD more than once a day, preferably prior to your heaviest meal, and consider taking a multivitamin. See the nutritional note.
References
Anderson, J. W. (1995). "Dietary fibre, complex carbohydrate and coronary artery disease." Can J Cardiol 11 Suppl G: 55G-62G.
Anderson, J. W., S. Riddell-Mason, N. J. Gustafson, S. F. Smith and M. Mackey (1992). "Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia." Am J Clin Nutr 56(1): 93-8.
Bell, L. P., K. J. Hectorn, H. Reynolds and D. B. Hunninghake (1990). "Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia." Am J Clin Nutr 52(6): 1020-6.
Delargy, H. J., K. R. O'Sullivan, R. J. Fletcher and J. E. Blundell (1997). "Effects of amount and type of dietary fibre (soluble and insoluble) on short-term control of appetite." Int J Food Sci Nutr 48(1): 67-77.
Han, L. K., Y. Kimura and H. Okuda (1999). "Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet." Int J Obes Relat Metab Disord 23(2): 174-9.
Hicks, V. A., S. C. Chen and D. Kritchevsky (1995). "The cholesterol-lowering properties of a psyllium-based breakfast cereal in hamsters." Artery 21(6): 352-61.
Kritchevsky, D., S. A. Tepper and D. M. Klurfeld (1995). "Influence of psyllium preparations on plasma and liver lipids of cholesterol-fed rats." Artery 21(6): 303-11.
Neal, G. W. and T. K. Balm (1990). "Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia." South Med J 83(10): 1131-7.
Roberts, D. C., A. S. Truswell, A. Bencke, H. M. Dewar and E. Farmakalidis (1994). "The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre." Med J Aust 161(11-12): 660-4.
Rodriguez-Moran, M., F. Guerrero-Romero and G. Lazcano-Burciaga (1998). "Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes." J Diabetes Complications 12(5): 273-8.
Tai, E. S., A. C. Fok, R. Chu and C. E. Tan (1999). "A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia." Ann Acad Med Singapore 28(2): 209-13.
Turnbull, W. H. and H. G. Thomas (1995). "The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake." Int J Obes Relat Metab Disord 19(5): 338-42.
Wuolijoki, E., T. Hirvela and P. Ylitalo (1999). "Decrease in serum LDL cholesterol with microcrystalline chitosan." Methods Find Exp Clin Pharmacol 21(5): 357-61.
Double-Blind Placebo-Controlled Trials As Cited at http://www.vanson.com/nut/lipo_tech.html
Abelin Jan and Lassus Allan. Ars Medicina, Helsinki, Finland. October 1994.
Ernst, E. and Pittler, M.H., Perfusion, 11, 1998, 461-465.
Giustina A. and Ventura P. Acta Toxical. Ther., Vol. XVI, no. 4. Oct./Dec. 1995. P. 199.
Krotkiewski, M, Zahorska-Markiewicz, B, Olszanecka-Glinianowicz, Zurakowski, A, Chitosan as an adjunct to dietary treatment of obesity. (Abstract) 3rd International Symposium on Chitin Anzymology and 4th Conference of the European Chitin Society, May 6-10, 2001, Senigallia, Italy.
Sciutto A.M. and Colombo P. Acta Toxical. Ther., Vol. XVI, no. 4. Oct./Dec. 1995. P. 215.
Yuji Maezaki, Keisuke Tsuji, Yasue Nakagawa et al. Biosc. Biotech. Biochem., Vol. 57, no. 9. 1993. P. 1439-1444.
This website and these statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Please consult a properly trained medical practitioner for medical advice.
